이범희 (울산대학교 의과대학)님 | 한빛사연구자 > 한빛사

울산대학교 의과대학

최종업데이트 2024.05.10.

Safety and efficacy of selumetinib in pediatric and adult patients with neurofibromatosis type 1 and plexiform neurofibroma
- Neuro-Oncology, Jul 08 2024, noae121 | https://doi.org/10.1093/neuonc/noae121
- 2024-07
- 의약학
- 한빛사논문
A 10-year follow-up of high-dose ambroxol treatment combined with enzyme replacement therapy for neuropathic Gaucher disease
- Am. J. Hematol., Apr 01 2024, | https://doi.org/10.1002/ajh.27302
- 2024-04
- 의약학
- 한빛사논문
Therapeutic gene correction for Lesch-Nyhan syndrome using CRISPR-mediated base and prime editing
- Mol. Ther.-Nucl. Acids, VOLUME 31, P586-595, MARCH 14, 2023 | https://doi.org/10.1016/j.omtn.2023.02.009
- 2023-03
- 의약학
- 한빛사논문
Identification of a novel therapeutic target underlying atypical manifestation of Gaucher disease
- Clin. Transl. Med., First published: 20 May 2022 | https://doi.org/10.1002/ctm2.862
- 2022-05
- 의약학
- 한빛사논문

연구자 ID

저자논문